An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 1, 2008, Pages 364-371

  Qi, Sheng ^a   Avalle, Paolo ^b   Saklatvala, Robert ^b   Craig, Duncan Q M ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b Merck Sharp & Dohme Limited   (United Kingdom)

Author keywords

Amorphous; Crystallisation; Glass; Paracetamol; Thermal

Indexed keywords

NITROGEN; PARACETAMOL;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; ENCAPSULATION; GLASS TRANSITION TEMPERATURE; MICROSCOPY;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DRUG STABILITY; GLASS; NITROGEN; PARTICLE SIZE; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; X-RAY DIFFRACTION;

EID: 41549102897     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.10.008     Document Type: Article

References (26)

1. Hancock B.C., and Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86 1 (1997) 1-12
2. Craig D.Q.M., Royall P., Kett V., and Hopton M. The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems. Int. J. Pharm. 179 (1999) 179-207
3. Aso Y., Yoshioka S., and Kojima S. Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by C-13 nuclear magnetic resonance relaxation time and the relaxation time obtained from the heating rate dependence of the glass transition temperaturem. J. Pharm. Sci. 90 (2001) 798-806
4. Hancock B.C., and Shamblin S.L. Molecular mobility of amorphous pharmaceuticals determined using differential scanning calorimetry. Thermochim. Acta 380 2 (2001) 95-107
5. Martino P.D., Guyot-Hermann A.M., Conflant P., Drache M., and Guyot J.C. A new pure paracetamol for direct compression: the orthorhombic form. Int. J. Pharm. 128 1-2 (1996) 1-8
6. Martino P.D., Conflant P., Drache M., Huvenne J.P., and Guyot-Hermann A.M. Preparation and physical characterization of forms II and III of paracetamol. J. Therm. Anal. Calorim. 48 3 (1997) 447-458
7. Martino P.D., Palmieri G.F., and Martelli S. Molecular mobility of the paracetamol amorphous form. Chem. Pharm. Bull. 48 8 (2000) 1105-1108
8. Nichols G., and Frampton C.S. Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution. J. Pharm. Sci. 87 6 (1998) 684-692
9. Boldyreva E.V., Drebushchak V.A., Paukov I.E., Kovalevskaya Y.A., and Drebushchak T.N. DSC and adiabatic calorimetry study of the polymorphs of paracetamol. J. Therm. Anal. Calorim. 77 2 (2004) 607-623
10. Boldyreva E.V., Shakhtshneider T.P., Ahsbahs H., Sowa H., and Uchtmann H. Effect of high pressure on the polymorphs of paracetamol. J. Therm. Anal. Calorim. 68 2 (2002) 437-452
11. Boldyreva E.V. High-pressure-induced structural changes in molecular crystals preserving the space group symmetry: anisotropic distortion/isosymmetric polymorphism. Cryst. Eng. 6 4 (2003) 235-254
12. Politov A.A., Kostrovskii V.G., and Boldyrev V.V. Conditions of preparation and crystallisation of amorphous paracetamol. Russ. J. Phys. Chem. 75 11 (2001) 1903-1911
13. Espeau P., Ceolin R., Tamarit J.L., Perrin M.A., Gauchi J.P., and Leveiller F. Polymorphism of paracetamol: relative stabilities of the monoclinic and orthorhombic phases inferred from topological pressure-temperature and temperature-volume phase diagrams. J. Pharm. Sci. 94 3 (2005) 524-539
14. Rossi A., Savioli A., Bini M., Capsoni D., Massarotti V., Bettini R., Gazzaniga A., Sangalli M.E., and Giordano F. Solid-state characterization of paracetamol metastable polymorphs formed in binary mixtures with hydroxypropylmethylcellulose. Thermochim. Acta 406 1-2 (2003) 55-67
15. Ivanova B.B. Monoclinic and orthorhombic polymorphs of paracetamol - solid state linear dichroic infrared spectral analysis. J. Mol. Struct. 738 1-3 (2005) 233-238
16. Wang S.L., Lin S.Y., and Wei Y.S. Transformation of metastable forms of acetaminophen studied by thermal fourier transform infrared (FT-IR) microspectroscopy. Chem. Pharm. Bull. 50 2 (2002) 153-156
17. Al-Zoubi N., Koundourellis J.E., and Malamataris S. FT-IR and Raman spectroscopic methods for identification and quantitation of orthorhombic and monoclinic paracetamol in powder mixes. J. Pharmaceut. Biomed. 29 3 (2002) 459-467
18. Boldyreva E.V., Shakhtshneider T.P., Vasilchenko M.A., Ahsbahs H., and Uchtmann H. Anisotropic crystal structure distortion of the monoclinic polymorph of acetaminophen at high hydrostatic pressures. Acta Crystallogr. B 56 2 (2000) 299-309
19. Johari G.P., Kim S., and Shanker R.M. Dielectric studies of molecular motions in amorphous solid and ultraviscous acetaminophen. J. Pharm. Sci. 94 10 (2005) 2207-2223
20. Angell C.A., Ngai K.L., McKenna G.B., McMillan P.F., and Martin S.W. Relaxation in glassforming liquids and amorphous solids. J. Appl. Phys. 88 6 (2000) 3113-3157
21. Hilden L.R., and Morris K.R. Physics of amorphous solids. J. Pharm. Sci. 93 1 (2004) 3-12
22. Wang L.M., Angell C.A., and Richert R. Fragility and thermodynamics in nonpolymeric glass-forming liquids. J. Chem. Phys. 125 7 (2006) 074505-1-8
23. Borde B., Bizot H., Vigier G., and Buleon A. Calorimetric analysis of the structural relaxation in partially hydrated amorphous polysaccharides. I. Glass transition and fragility. Carbohydr. Polym. 48 1 (2002) 83-96
24. In: Craig D.Q.M., and Reading M. (Eds). Thermal Analysis of Pharmaceuticals (2007), CRC press 180-188
25. Ostwald W. Studien uber die Bildung und Umwandlung fester Korper. Z. Physik. Chem. 22 (1897) 289-330
26. Carpentier L., Decressain R., Desprez S., and Descamps M. Dynamics of the Amorphous and Crystalline α-, β-Phases of Indomethacin. J. Phys. Chem. B 110 1 (2006) 457-464